Pediatrix Medical Group I... (MD)
NYSE: MD
· Real-Time Price · USD
15.80
0.26 (1.67%)
At close: Aug 15, 2025, 12:17 PM
Pediatrix Medical Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 1.94B | 1.98B | 2.01B | 2.01B | 2B | 2B | 1.99B | 2.01B | 2B | 1.98B | 1.97B | 1.96B | 1.96B | 1.95B | 1.91B | 1.83B | 1.8B | 1.83B |
Cost of Revenue | 1.47B | 1.52B | 1.58B | 1.6B | 1.6B | 1.59B | 1.57B | 1.58B | 1.55B | 1.53B | 1.5B | 1.47B | 1.45B | 1.43B | 1.4B | 1.35B | 1.32B | 1.35B |
Gross Profit | 465.84M | 446.44M | 428.37M | 407.89M | 397.95M | 408.08M | 421.56M | 436.2M | 444.52M | 454.5M | 467.03M | 489.13M | 511.99M | 518.3M | 513.24M | 482.96M | 473.19M | 479.95M |
Operating Income | 165.09M | 153.98M | 146.25M | -4.53M | 1.92M | 1.65M | 7.32M | 174.83M | 181.94M | 183.6M | 192.67M | 204.66M | 216.06M | 215.92M | 202.92M | 167.22M | 128.88M | 113.78M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 141.62M | -81.08M | -101.34M | -273.52M | -267.92M | -61.25M | -48.36M | 118.31M | 126.34M | 130.43M | 81.37M | 107.06M | 111.64M | 106.49M | 135.23M | 92.07M | 52.66M | 25.74M |
Net Income | 109.92M | -82.37M | -99.07M | -253.84M | -233M | -51.7M | -41.53M | 112.42M | 102.88M | 101.73M | 66.58M | 84.44M | 84.5M | 92.38M | 130.96M | 19.15M | -52.69M | -760.13M |
Selling & General & Admin | 235.99M | 236.84M | 238.44M | 227.95M | 227.23M | 228.68M | 227.54M | 225.53M | 226.02M | 229.17M | 231.4M | 239.32M | 248.32M | 258.13M | 263.36M | 259.05M | 258.5M | 265.21M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 45.96M | 36.81M | 24.87M | 184.47M | 168.8M | 177.75M | 186.7M | 36.24M | 35.99M | 35.82M | 35.64M | 34.36M | 33.55M | 32.88M | 32.15M | 31.98M | 31.02M | 37.31M |
Operating Expenses | 281.95M | 273.65M | 263.31M | 261.88M | 245.51M | 255.9M | 263.71M | 261.78M | 262.01M | 264.99M | 267.03M | 273.68M | 281.88M | 291.01M | 295.5M | 291.03M | 289.52M | 302.52M |
Interest Expense | 38.12M | 39.3M | 40.74M | 41.11M | 41.36M | 42.28M | 42.08M | 41.95M | 41.09M | 38.27M | 39.7M | 46.35M | 54.42M | 62.9M | 68.72M | 79.42M | 89.08M | 100.46M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.78B | 1.82B | 1.87B | 1.86B | 1.85B | 1.85B | 1.84B | 1.84B | 1.81B | 1.79B | 1.77B | 1.74B | 1.73B | 1.72B | 1.69B | 1.64B | 1.61B | 1.66B |
Income Tax Expense | 31.7M | 1.29M | -2.27M | -19.68M | -34.92M | -9.55M | -6.83M | 11.55M | 31.05M | 32.71M | 18.81M | 28.22M | 29.76M | 24.8M | 27.24M | 19.87M | 14.95M | 10.96M |
Shares Outstanding (Basic) | 86.85M | 85.81M | 85.87M | 83.89M | 83.33M | 84.01M | 84.02M | 82.54M | 82.4M | 81.89M | 82.95M | 82.13M | 85.08M | 84.74M | 85.07M | 85.06M | 84.91M | 84.53M |
Shares Outstanding (Diluted) | 86.85M | 85.81M | 85.87M | 84.52M | 83.33M | 83.28M | 82.66M | 82.95M | 82.66M | 82.32M | 82.95M | 82.78M | 85.62M | 85.41M | 86.42M | 86.1M | 85.93M | 85.49M |
EPS (Basic) | 1.27 | -1.02 | -1.21 | -3.04 | -2.78 | -0.6 | -0.48 | 1.36 | 1.24 | 1.22 | 0.80 | 0.99 | 0.98 | 1.07 | 1.53 | 0.21 | -0.64 | -9.1 |
EPS (Diluted) | 1.27 | -1.02 | -1.21 | -3.06 | -2.8 | -0.62 | -0.5 | 1.36 | 1.24 | 1.22 | 0.80 | 0.99 | 0.98 | 1.07 | 1.53 | 0.23 | -0.62 | -9.06 |
EBITDA | 203.51M | -14.53M | -22.42M | -192.04M | -184.17M | 21.9M | 26.21M | 210.67M | 218.51M | 225.33M | 178.58M | 192.75M | 206.61M | 203.11M | 249.88M | 223.91M | 214.68M | 205.71M |
EBIT | 179.74M | -41.78M | -54.65M | -226.46M | -221.54M | -15.63M | -9.96M | 174.43M | 182.52M | 189.51M | 142.94M | 158.39M | 173.05M | 170.23M | 217.74M | 191.94M | 183.66M | 169.44M |
Depreciation & Amortization | 23.77M | 27.25M | 32.23M | 34.41M | 37.37M | 37.53M | 36.17M | 36.24M | 35.99M | 35.82M | 35.64M | 34.36M | 33.55M | 32.88M | 32.15M | 31.98M | 15.79M | 17.8M |